Hartman Curt R 4
4 · CONMED Corp · Filed Sep 17, 2021
Insider Transaction Report
Form 4
CONMED CorpCNMD
Hartman Curt R
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-15$39.87/sh+34,000$1,355,580→ 98,980 total - Sale
Common Stock
2021-09-15$127.39/sh−2,500$318,468→ 64,980 total - Tax Payment
Common Stock
2021-09-15$127.24/sh−19,349$2,462,015→ 79,631 total - Tax Payment
Common Stock
2021-09-15$127.28/sh−28,182$3,587,005→ 98,949 total - Gift
Common Stock
2021-09-17+89,000→ 89,000 total(indirect: By Trust) - Exercise/Conversion
Options To Purchase Common Stock
2021-09-15−47,500→ 111,650 totalExercise: $41.93Exp: 2027-03-01→ Common Stock (47,500 underlying) - Exercise/Conversion
Common Stock
2021-09-15$41.93/sh+47,500$1,991,675→ 127,131 total - Gift
Common Stock
2021-09-17−89,000→ 9,949 total - Exercise/Conversion
Options To Purchase Common Stock
2021-09-15−34,000→ 0 totalExercise: $39.87Exp: 2026-03-01→ Common Stock (34,000 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F2]This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
- [F3]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.